|
1
|
Cancer Genome Atlas Research Network:
Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 159:676–690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Londero SC, Krogdahl A, Bastholt L,
Overgaard J, Trolle W, Pedersen HB, Bentzen J, Schytte S,
Christiansen P and Godballe C; Danish Thyroid Cancer Group, :
Papillary thyroid microcarcinoma in Denmark 1996–2008: A national
study of epidemiology and clinical significance. Thyroid.
23:1159–1164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olaleye O, Ekrikpo U, Moorthy R, Lyne O,
Wiseberg J, Black M and Mitchell D: Increasing incidence of
differentiated thyroid cancer in South East England: 1987–2006. Eur
Arch Otorhinolaryngol. 268:899–906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hay ID, Thompson GB, Grant CS, Bergstralh
EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL,
et al: Papillary thyroid carcinoma managed at the Mayo Clinic
during six decades (1940–1999): Temporal trends in initial therapy
and long-term outcome in 2444 consecutively treated patients. World
J Surg. 26:879–885. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ito Y, Miyauchi A, Kudo T, Kihara M,
Fukushima M and Miya A: The effectiveness of prophylactic modified
neck dissection for reducing the development of lymph node
recurrence of papillary thyroid carcinoma. World J Surg.
41:2283–2289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang N, Jiang R, Yang JY, Tang C, Yang L,
Xu M, Jiang QF and Liu ZM: Expression of TGF-β1, SNAI1 and MMP-9 is
associated with lymph node metastasis in papillary thyroid
carcinoma. J Mol Histol. 45:391–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MM, Fu WM and Zhang JF: LncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shaha AR, Shah JP and Loree TR: Risk group
stratification and prognostic factors in papillary carcinoma of
thyroid. Ann Surg Oncol. 3:534–538. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zerilli M, Zito G, Martorana A, Pitrone M,
Cabibi D, Cappello F, Giordano C and Rodolico V: BRAF(V600E)
mutation influences hypoxia-inducible factor-1alpha expression
levels in papillary thyroid cancer. Modern Pathol. 23:1052–1060.
2010. View Article : Google Scholar
|
|
13
|
Boelaert K, Horacek J, Holder RL,
Watkinson JC, Sheppard MC and Franklyn JA: Serum thyrotropin
concentration as a novel predictor of malignancy in thyroid nodules
investigated by fine-needle aspiration. J Clin Endocrinol Metabol.
91:4295–4301. 2006. View Article : Google Scholar
|
|
14
|
Derynck R, Akhurst RJ and Balmain A:
TGF-Beta signaling in tumor suppression and cancer pr. Nat Gene.
29:117–129. 2001. View Article : Google Scholar
|
|
15
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hundt S, Haug U and Brenner H: Blood
markers for early detection of colorectal cancer: A systematic
review. Cancer Epidemiol Biomarkers Prev. 16:1935–1953. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee CK, Klopp RG, Weindruch R and Prolla
TA: Gene expression profile of aging and its retardation by caloric
restriction. Science. 285:1390–1393. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou W, Liu G, Park S, Wang Z, Wain JC,
Lynch TJ, Su L and Christiani DC: Gene-smoking interaction
associations for the ERCC1 polymorphisms in the risk of lung
cancer. Cancer Epidemiol Biomarkers Prev. 14:491–496. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Corella D: Gene-alcohol interactions in
the metabolic syndrome. Nutr Metab Cardiovasc Dis. 17:140–147.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang Y, Zheng Y, Jia L and Li W: Long
Noncoding RNA H19 promotes osteoblast differentiation via
TGF-β1/Smad3/HDAC signaling pathway by deriving miR-675. Stem
Cells. 33:3481–3492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
